首页|食管癌中B7H3的表达及其CAR-T细胞抗肿瘤作用研究

食管癌中B7H3的表达及其CAR-T细胞抗肿瘤作用研究

The Expression of B7H3 in Esophageal Carcinoma and the Antitumor Effect of CAR-T Cells

扫码查看
目的 构建靶向B7H3的CAR-T细胞,研究其对食管癌KYSE150细胞的抑制作用.方法 采用免疫组化SP法检测B7H3蛋白在20例食管癌组织及20例癌旁组织中的表达,同时对患者临床病理资料的相关性进行了分析;利用慢病毒载体制备靶向B7H3-CAR-T细胞,荧光显微镜观察CAR-T细胞转染效率;通过用不同的效靶比共培养检测CAR-T细胞对KYSE150细胞的杀伤能力;利用ELISA试剂盒检测上清液中释放的细胞因子含量.结果 食管癌组织B7H3的表达明显高于癌旁组织,且B7H3蛋白的表达与浸润深度、pTNM分期、淋巴结转移及肿瘤直径有显著相关性(P<0.05);与患者性别、年龄、吸烟、饮酒、肿瘤位置及分化程度无关(P>0.05);通过慢病毒侵染得到结构优化的新型CAR-T细胞;当效靶比为10:1时,B7H3-CAR-T细胞展现出更强的杀伤能力,并发现不同效靶比下的IL-2和IFN-γ分泌水平都显著高于T细胞.结论 成功制备出靶向B7H3-CAR-T细胞,能够有效杀伤B7H3阳性的食管癌KYSE150细胞.
Objective To construct CAR-T cells targeting B7H3 and study its inhibitory effect on KYSE150 cells of esophageal carcinoma.Methods The expression of B7H3 in esophageal cancer tissues and adjacent tissues was detected by immunohistochemistry,and the correlation between the expression of B7H3 protein in esophageal cancer tissues and clinicopathological features of patients was analyzed.Lentiviral vector was used to prepare B7H3-CAR-T cells,and the stability efficiency of CAR-T cells was observed by fluorescence mi-croscope.The killing ability of CAR-T cells to KYSE150 cells was detected by co-culture with different efficiency target ratio.The cytokines released in the supernatant were detected by ELISA kit.Results The expression of B7H3 in esophageal carcinoma tissues was significantly higher than that in adjacent tissues,and the expres-sion of B7H3 protein was significantly correlated with the depth of invasion,pTNM stage,lymph node metas-tasis and length of lesion(P<0.05).There was no correlation with gender,age,smoking,drinking,location of tumor and differentiation degree(P>0.05).The novel CAR-T cells with optimized structure were obtained by lentivirus infection.When the effect-target ratio was 10∶1,B7H3-CAR-T cells showed stronger killing a-bility,and the secretion levels of IL-2 and IFN-γ were significantly higher than that of T cells at different effect-target ratios.Conclusion B7H3-targeted CAR-T cells were successfully prepared,which can effec-tively kill B7H3-positive esophageal cancer KYSE150 cells.

B7H3chimeric antigen receptor T cellsesophageal cancercellular immunotherapy

魏熠珊、韦曌怡、杨如月、梁高峰

展开 >

嵩县人民医院,河南嵩县,471400

河南科技大学基础医学与法医学院,河南洛阳,471023

B7H3 嵌合抗原受体T细胞 食管癌 细胞免疫治疗

河南省重点研发专项

221111310600

2024

食管疾病
河南科技大学

食管疾病

ISSN:2096-7381
年,卷(期):2024.6(3)